Who Paid My Doc
AMG 397_Combo in multiple hematologic indications_20170173
Research payments
$955,499
Through program year 2021, $955,499 in research payments was reported against AMG 397_Combo in multiple hematologic indications_20170173, across 134 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $75,942 | 18 |
| 2020 | Research | $107,717 | 56 |
| 2019 | Research | $771,839 | 60 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ashkan Emadi Baltimore, MD Named on 14 payments
- Tapan Kadia Houston, TX Named on 12 payments
- Saurabh Chhabra Charleston, SC Named on 11 payments
- Sikander Ailawadhi Jacksonville, FL Named on 9 payments
- Wilson Gonsalves Rochester, MN Named on 7 payments
- Eytan Stein New York, NY Named on 7 payments
- Jeremy Larsen Scottsdale, AZ Named on 6 payments
- Luciano Costa Birmingham, AL Named on 5 payments
- Geoffrey Uy Saint Louis, MO Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.